Filing Details
- Accession Number:
- 0001209191-13-021146
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-04-11 16:41:55
- Reporting Period:
- 2013-04-09
- Filing Date:
- 2013-04-11
- Accepted Time:
- 2013-04-11 16:41:55
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1100962 | Endo Health Solutions Inc. | ENDP | Pharmaceutical Preparations (2834) | 134022871 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1179357 | B Caroline Manogue | C/O Endo Health Solutions Inc. 1400 Atwater Drive Malvern PA 19355 | Exec. V.p., Clo & Secy | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value, $.01 Per Share | Acquisiton | 2013-04-09 | 35,000 | $15.24 | 97,014 | No | 4 | M | Direct | |
Common Stock, Par Value, $.01 Per Share | Disposition | 2013-04-09 | 35,000 | $35.00 | 62,014 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | 2000 Stock Incentive Plan Stock Options (NQ) | Disposition | 2013-04-09 | 35,000 | $0.00 | 35,000 | $15.24 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2013-08-05 | No | 4 | M | Direct |
Footnotes
- On June 8, 2012, Ms. Manogue placed 35,000 of the shares underlying her stock options into a 10b5-1 pre-set selling program until the earlier of August 5, 2013 or the date all shares under the program are sold (the "Manogue Pre-Set Selling Program"). The options exercised and the shares sold here were sold pursuant to the Manogue Pre-Set Selling Program, which leaves no remaining shares (underlying options) in the current Manogue Pre-Set Selling Program.
- This represents the price at which Ms. Manogue's common shares were sold on April 9, 2013.
- Ms. Manogues's stock options that were granted under the 2000 Stock Incentive Plan on August 5, 2003, were generally exercisable 25% per year on each of August 5, 2004, August 5, 2005, August 5, 2006 and August 5, 2007.
- These securities were granted to Ms. Manogue in 2003 in consideration of her services as the Senior Vice President, General Counsel and Secretary of Endo Health Solutions Inc.